Eusa Pharma

Recent executive movements at Jazz Pharmaceuticals

Mark Smith will join the company as Director on Dec. 1, 2020  (news posted on November 17 2020).
Jennifer Cook will join the company as Director on Dec. 1, 2020  (news posted on November 17 2020).
Jennifer Cook will join the company as Director on Dec. 1, 2020  (news posted on November 17 2020).

Click here to view some more movements at Jazz Pharmaceuticals

Create an alert
to follow the executive moves at Eusa Pharma.

Most searched biographies at Eusa Pharma

• Lee Morley, Chief Executive Officer and Director
• Bryan Morton, Chairman of the Board
• Evis Hursever, Director

Click on an executive to view his biography >

Latest M&A news in Pharmaceuticals.

Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).

Other contacts in the Pharmaceuticals industry

• Albert Bourla - Chief Executive Officer and Chairman of the Board at Pfizer
• Per-Olof Attinger - Executive Committee Secretary at Roche
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann

Learn more about the Pharmaceuticals industry >

Latest news about Eusa Pharma

Eusa Pharma on Wikipedia, Google News & Yahoo Finance

Eusa Pharma on LinkedIn, Twitter & YouTube

Eusa Pharma has 2,035 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland). Eusa Pharma is owned by Jazz Pharmaceuticals.

Contact by email its executives including Lee Morley

Call Eusa Pharma at +1 215....

View the org chart

Register to receive your alert

Report an error